Even if a woman has the expensive BRCA test, and she does not have the genes BRCA1 and BRCA2 that are linked with aggressive hereditary breast cancer and ovarian cancer, she still needs an OmniBody Scan test. In families riddled with breast cancer, a BRCA gene is the culprit only in roughly one family of every five that gets tested, said University of Toronto cancer specialist Dr. Steven Narod. Women are at risk even if they test free of the disease's most common gene mutations


Breast cancer is a leading cause of “cancer related deaths” among women in the United States, according to the American Cancer Society. And, 25% percent of all diagnosed cases are among women younger than age 50.


Advanced imaging techniques, molecular and protein biomarkers, and multimodal approaches are at the forefront of promising strategies for detecting and diagnosing cancer at its earliest, most treatable stages.


Breast thermography is a screening diagnostic procedure that uses highly specialized infrared cameras to measure the heat coming from the body. The OmniBody Scan is the premier infrared camera. Breast thermography has the ability to warn women, up to 10 years before any other procedure, that a cancer may be forming.


Thermography has been approved for many years by the FDA.